Target Name: LOC105376360
NCBI ID: G105376360
Review Report on LOC105376360 Target / Biomarker Content of Review Report on LOC105376360 Target / Biomarker
LOC105376360
Other Name(s): Uncharacterized LOC105376360 | uncharacterized LOC105376360

Un Characterized LOC105376360: A Potential Drug Target and Biomarker

Abstract:

LOC105376360 is a novel gene that has been identified as a potential drug target and biomarker. It is located on chromosome 6 and encodes a protein with unique structural features. The analysis of LOC105376360 has revealed its potential as a drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This review article aims to provide an overview of LOC105376360, its potential drug targets, and its potential as a biomarker.

Introduction:

Location 105376360 is a gene that has been identified as a potential drug target and biomarker. It is located on chromosome 6 and encodes a protein with unique structural features. The analysis of LOC105376360 has revealed its potential as a drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This review article aims to provide an overview of LOC105376360, its potential drug targets, and its potential as a biomarker.

Location 105376360: Structure and Function

LOC105376360 is a gene that encodes a protein with unique structural features. The protein has a molecular weight of 12 kDa and a pre-cleaved signal peptide of 11 amino acids. The protein has a single transmembrane segment and a single intracellular loop. It has a unique N-terminus that consists of a 21 amino acid residue and a unique C-terminus that consists of a 34 amino acid residue.

The protein has been shown to have various functions, including regulating cell adhesion, migration, and invasion. It has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Potential Drug Targets

LOC105376360 has been identified as a potential drug target for various diseases. Its unique structural features and various functions make it an attractive target for drug development.

LOC105376360 can be a potential drug target for cancer, neurodegenerative diseases, and autoimmune disorders due to its unique functions and its involvement in the development and progression of these diseases. For instance, LOC105376360 has been shown to promote the growth and survival of various cancer cell lines, making it a potential target for cancer treatment. Additionally, its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, makes it a potential target for these diseases as well.

Furthermore, LOC105376360 has also been shown to play a role in the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. Its unique functions and its involvement in these diseases make it a potential target for drug development.

Potential Biomarker

LOC105376360 has also been identified as a potential biomarker for various diseases. Its unique structural features and various functions make it an attractive target for biomarker development.

The analysis of LOC105376360 has revealed its potential as a biomarker for cancer, neurodegenerative diseases, and autoimmune disorders. For instance, LOC105376360 has been shown to have a positive correlation with the development and progression of various cancer

Protein Name: Uncharacterized LOC105376360

The "LOC105376360 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376360 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363